Representative Jeff Duncan asks FDA to hold a public hearing on NMN decision
Representative Jeff Duncan, a republican congressman representing South Carolina’s 3rd District, has sent a letter to the U.S. Food and Drug Administration’s Commissioner, Robert M. Califf, MD, asking the Agency to hold public hearing on NMN decision.
Photo © AdobeStock.com/gustavofrazao
Representative Jeff Duncan, a republican congressman representing South Carolina’s 3rd District, has sent a letter to the U.S. Food and Drug Administration’s (FDA) Commissioner, Robert M. Califf, MD, with regard to the agency’s decision that beta-nicotinamide mononucleotide (NMN) did not meet the definition of a dietary ingredient, citing drug preclusion. The letter, first reported on by Natural Products Insider and published by the Natural Products Association (NPA; Washington, D.C.), requests that FDA hold a public hearing to clarify its position given the Agency’s “sudden change of policy.”
The letter also asked FDA to respond to a number of questions, including whether the Agency has been in contact with e-commerce platforms regarding the sale of NMN, given the restrictions platforms such as Amazon have implemented against the sale of said products. Additionally, Duncan is asking for information that would help determine the timeline between NMN’s presence in the marketplace as a dietary ingredient and its investigation as a new drug, as well as the differences between drug and dietary supplement product composition.
Duncan is giving FDA until May 11, 2023 to respond to the letter.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
